{"id":"https://openalex.org/W1995377218","doi":"https://doi.org/10.1128/aac.00222-12","title":"Single-Dose Phase I Study To Evaluate the Pharmacokinetics of Posaconazole in New Tablet and Capsule Formulations Relative to Oral Suspension","display_name":"Single-Dose Phase I Study To Evaluate the Pharmacokinetics of Posaconazole in New Tablet and Capsule Formulations Relative to Oral Suspension","alternate_titles":[],"publication_year":2012,"publication_date":"2012-05-22","ids":{"openalex":"https://openalex.org/W1995377218","doi":"https://doi.org/10.1128/aac.00222-12","mag":"1995377218","pmid":"https://pubmed.ncbi.nlm.nih.gov/22615291","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3421591"},"language":"en","primary_location":{"id":"doi:10.1128/aac.00222-12","doi":"https://doi.org/10.1128/aac.00222-12","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.00222-12","pdf_url":"https://aac.asm.org/content/aac/56/8/4196.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1995377218"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aac.asm.org/content/aac/56/8/4196.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004765077","display_name":"Gopal Krishna","orcid":"https://orcid.org/0000-0002-3163-3009","observed_orcids":["https://orcid.org/0000-0002-3163-3009"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Gopal Krishna","raw_affiliation_strings":["Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101681989","display_name":"Lei Ma","orcid":"https://orcid.org/0000-0001-7502-446X","observed_orcids":["https://orcid.org/0000-0001-7502-446X"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lei Ma","raw_affiliation_strings":["Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109401795","display_name":"Monika Martinho","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Monika Martinho","raw_affiliation_strings":["Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109985651","display_name":"Edward M. O'Mara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Edward O'Mara","raw_affiliation_strings":["Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, USA","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5004765077"],"corresponding_institution_ids":["https://openalex.org/I1285764155"],"apc_list":null,"apc_paid":null,"fwci":9.233,"has_fulltext":true,"cited_by_count":165,"citation_normalized_percentile":{"value":0.98638002,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"56","issue":"8","first_page":"4196","last_page":"4201"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.948199987411499,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.948199987411499,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.021199999377131462,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.012000000104308128,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/posaconazole","display_name":"posaconazole","score":0.9829999804496765},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9639999866485596},{"id":"https://openalex.org/keywords/tablet-formulation","display_name":"tablet formulation","score":0.7200000286102295},{"id":"https://openalex.org/keywords/capsule-formulation","display_name":"capsule formulation","score":1.0},{"id":"https://openalex.org/keywords/oral-suspension","display_name":"oral suspension","score":0.9900000095367432},{"id":"https://openalex.org/keywords/food-effect","display_name":"food effect","score":0.7369999885559082},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.6230000257492065},{"id":"https://openalex.org/keywords/triazole-antifungals","display_name":"triazole antifungals","score":0.8330000042915344},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.6320000290870667},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.7440000176429749},{"id":"https://openalex.org/keywords/high-fat-meal","display_name":"high-fat meal","score":0.46000000834465027},{"id":"https://openalex.org/keywords/half-life","display_name":"half-life","score":0.5879999995231628},{"id":"https://openalex.org/keywords/drug-formulation-comparison","display_name":"drug formulation comparison","score":0.38100001215934753},{"id":"https://openalex.org/keywords/antifungal-prophylaxis","display_name":"antifungal prophylaxis","score":0.8059999942779541},{"id":"https://openalex.org/keywords/antifungal-therapy","display_name":"antifungal therapy","score":0.7720000147819519},{"id":"https://openalex.org/keywords/crossover-design","display_name":"crossover design","score":0.3449999988079071},{"id":"https://openalex.org/keywords/single-dose-administration","display_name":"single-dose administration","score":0.503000020980835}],"concepts":[{"id":"https://openalex.org/C2778566413","wikidata":"https://www.wikidata.org/wiki/Q906453","display_name":"Posaconazole","level":4,"score":0.861445426940918},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.811226487159729},{"id":"https://openalex.org/C2778778583","wikidata":"https://www.wikidata.org/wiki/Q147768","display_name":"Capsule","level":2,"score":0.7517067193984985},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5384236574172974},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4923304319381714},{"id":"https://openalex.org/C105341887","wikidata":"https://www.wikidata.org/wiki/Q1307987","display_name":"Suspension (topology)","level":3,"score":0.488841712474823},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.15506047010421753},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1376703977584839},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.10914850234985352},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.10069340467453003},{"id":"https://openalex.org/C2777071850","wikidata":"https://www.wikidata.org/wiki/Q411229","display_name":"Itraconazole","level":3,"score":0.06807839870452881},{"id":"https://openalex.org/C5961521","wikidata":"https://www.wikidata.org/wiki/Q746083","display_name":"Homotopy","level":2,"score":0.0},{"id":"https://openalex.org/C202444582","wikidata":"https://www.wikidata.org/wiki/Q837863","display_name":"Pure mathematics","level":1,"score":0.0},{"id":"https://openalex.org/C59822182","wikidata":"https://www.wikidata.org/wiki/Q441","display_name":"Botany","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D002214","descriptor_name":"Capsules","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004435","descriptor_name":"Eating","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005215","descriptor_name":"Fasting","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013535","descriptor_name":"Suspensions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013607","descriptor_name":"Tablets","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D018565","descriptor_name":"Food-Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1128/aac.00222-12","doi":"https://doi.org/10.1128/aac.00222-12","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.00222-12","pdf_url":"https://aac.asm.org/content/aac/56/8/4196.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2425258","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3421591","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3421591","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3421591/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:22615291","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22615291","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":{"id":"doi:10.1128/aac.00222-12","doi":"https://doi.org/10.1128/aac.00222-12","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.00222-12","pdf_url":"https://aac.asm.org/content/aac/56/8/4196.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1995377218.pdf","grobid_xml":"https://content.openalex.org/works/W1995377218.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W1556593209","https://openalex.org/W1736726786","https://openalex.org/W1981516536","https://openalex.org/W1984228185","https://openalex.org/W1988385266","https://openalex.org/W1989345554","https://openalex.org/W2011947169","https://openalex.org/W2027445904","https://openalex.org/W2032771458","https://openalex.org/W2042500043","https://openalex.org/W2071342876","https://openalex.org/W2097822381","https://openalex.org/W2102649824","https://openalex.org/W2106243271","https://openalex.org/W2117813373","https://openalex.org/W2119544769","https://openalex.org/W2138866540","https://openalex.org/W2142996250","https://openalex.org/W2155149156","https://openalex.org/W2162626697","https://openalex.org/W2418920851","https://openalex.org/W4387990116"],"related_works":["https://openalex.org/W2969608688","https://openalex.org/W1736726786","https://openalex.org/W4313649238","https://openalex.org/W1883163115","https://openalex.org/W2150902931","https://openalex.org/W2330130059","https://openalex.org/W2117813373","https://openalex.org/W2080318677","https://openalex.org/W2152923337","https://openalex.org/W2067101775"],"abstract_inverted_index":{"Posaconazole":[0],"oral":[1,71,145,165,208,263],"suspension,":[2],"a":[3,274],"marketed":[4],"extended-spectrum":[5],"triazole":[6],"with":[7,18,257,273],"proven":[8],"efficacy":[9],"as":[10],"antifungal":[11],"treatment":[12],"and":[13,25,37,63,75,78,82,97,136,156,171,202,232,249,281,298],"prophylaxis,":[14],"should":[15],"be":[16],"taken":[17],"food":[19],"to":[20,34,57,67,79,107,217,227,234,253,267],"maximize":[21],"absorption.":[22],"New":[23],"tablet":[24,62,96,110,121,180,187],"capsule":[26,64,98,157,172,282],"formulations":[27,65,99,246,290],"have":[28],"been":[29],"developed":[30],"in":[31,52,161,174,223],"an":[32],"attempt":[33],"optimize":[35],"absorption":[36],"bioavailability.":[38],"The":[39],"aims":[40],"of":[41,117,221,291],"this":[42],"exploratory":[43],"open-label,":[44],"partially":[45],"randomized,":[46],"2-part,":[47],"4-way,":[48],"single-dose":[49],"crossover":[50],"study":[51],"16":[53],"healthy":[54],"adults":[55],"were":[56,100,137,225,242,283,296],"characterize":[58],"pharmacokinetics":[59],"for":[60,69,94,143,244,261,279],"posaconazole":[61,70,87,292],"relative":[66],"those":[68],"suspension":[72,146,209,264],"under":[73,90,247],"fasted":[74,85,250],"fed":[76,168,248],"conditions":[77,251],"assess":[80],"safety":[81],"tolerability.":[83],"Under":[84],"conditions,":[86],"exposures":[88,278],"(area":[89],"the":[91,95,141,144,164,207,218,262],"curve":[92],"[AUC])":[93],"similar":[101,175,243],"(mean":[102,147,178,210],"AUC":[103,176],"from":[104],"time":[105],"zero":[106],"infinity":[108],"[AUC(0-\u221e)],":[109],"A,":[111,181],"11,700":[112],"ng":[113,124,131,150,183,190,197],"\u00b7":[114,125,132,151,184,191,198],"h/ml":[115,126,133,152,185,192,199],"[coefficient":[116],"variation":[118],"{CV},":[119],"26%];":[120],"B,":[122,188],"11,300":[123],"[CV,":[127,134,153,193,200,213],"22%];":[128],"capsule,":[129,195],"11,000":[130],"25%])":[135],"substantially":[138],"higher":[139,204],"than":[140,163,206],"exposure":[142,162,205,260],"AUC(0-\u221e),":[148,179,211],"3,420":[149],"44%]).":[154],"Tablets":[155],"showed":[158],"less":[159],"variability":[160],"suspension.":[166],"In":[167],"subjects,":[169],"tablets":[170,280],"resulted":[173],"values":[177,241],"11,900":[182],"[23%];":[186],"12,400":[189],"25%];":[194],"12,300":[196],"28%])":[201],"slightly":[203],"8,750":[212],"24%]).":[214],"Median":[215],"times":[216],"maximum":[219],"concentration":[220],"drug":[222],"plasma":[224],"4":[226],"5":[228],"h":[229,236],"(fasted":[230],"conditions)":[231],"6":[233],"8":[235],"(fed":[237],"conditions).":[238],"Mean":[239],"half-lives":[240],"all":[245],"(23.1":[252],"29.2":[254],"h).":[255],"Consistent":[256],"previous":[258],"data,":[259],"increased":[265],"2.5-":[266],"3-fold":[268],"when":[269],"it":[270],"was":[271],"given":[272],"high-fat":[275],"meal.":[276],"Conversely,":[277],"not":[284],"markedly":[285],"affected":[286],"by":[287],"food.":[288],"All":[289],"at":[293],"100":[294],"mg":[295],"safe":[297],"well":[299],"tolerated.":[300]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1995377218","counts_by_year":[{"year":2026,"cited_by_count":13},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":19},{"year":2015,"cited_by_count":20},{"year":2014,"cited_by_count":18},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
